MA30152B1 - Suspension de fexofenadine - Google Patents

Suspension de fexofenadine

Info

Publication number
MA30152B1
MA30152B1 MA31103A MA31103A MA30152B1 MA 30152 B1 MA30152 B1 MA 30152B1 MA 31103 A MA31103 A MA 31103A MA 31103 A MA31103 A MA 31103A MA 30152 B1 MA30152 B1 MA 30152B1
Authority
MA
Morocco
Prior art keywords
fexofenadine
suspension
relates
present
aqueous pharmaceutical
Prior art date
Application number
MA31103A
Other languages
English (en)
Inventor
Prafulla Agrawala
Kazimierz Chrzan
Rajiv Haribhakti
Matthew Mermey
Curtis J Porcello
Gary Lee Silvey
Vinh Tran
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38120312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30152(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of MA30152B1 publication Critical patent/MA30152B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne une suspension pharmaceutique aqueuse d'un dihydrate zwitterionique de fexofénadine de forme 1.
MA31103A 2005-12-14 2008-07-11 Suspension de fexofenadine MA30152B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75030305P 2005-12-14 2005-12-14

Publications (1)

Publication Number Publication Date
MA30152B1 true MA30152B1 (fr) 2009-01-02

Family

ID=38120312

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31103A MA30152B1 (fr) 2005-12-14 2008-07-11 Suspension de fexofenadine

Country Status (38)

Country Link
US (1) US8933097B2 (fr)
EP (1) EP1965768B1 (fr)
JP (1) JP5308824B2 (fr)
KR (1) KR101452792B1 (fr)
CN (1) CN101316580B (fr)
AR (1) AR058323A1 (fr)
AT (1) ATE431137T1 (fr)
AU (1) AU2006326551B2 (fr)
BR (1) BRPI0619895B1 (fr)
CA (1) CA2633086C (fr)
CR (1) CR9993A (fr)
CY (1) CY1109320T1 (fr)
DE (1) DE602006006870D1 (fr)
DK (1) DK1965768T3 (fr)
DO (1) DOP2006000274A (fr)
EC (1) ECSP088532A (fr)
EG (1) EG25866A (fr)
ES (1) ES2327168T3 (fr)
HN (1) HN2008000875A (fr)
HR (1) HRP20090411T1 (fr)
IL (1) IL192067A (fr)
JO (1) JO2549B1 (fr)
MA (1) MA30152B1 (fr)
MY (1) MY146988A (fr)
NO (1) NO339877B1 (fr)
NZ (1) NZ568943A (fr)
PE (1) PE20071003A1 (fr)
PL (1) PL1965768T3 (fr)
PT (1) PT1965768E (fr)
RS (1) RS51135B (fr)
RU (1) RU2405538C2 (fr)
SI (1) SI1965768T1 (fr)
TN (1) TNSN08186A1 (fr)
TW (1) TWI377061B (fr)
UA (1) UA89584C2 (fr)
UY (1) UY30021A1 (fr)
WO (1) WO2007070517A2 (fr)
ZA (1) ZA200803985B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101546774B1 (ko) 2008-07-29 2015-08-24 엘지전자 주식회사 휴대 단말기 및 그 동작제어 방법
EP2768488A4 (fr) 2011-10-19 2015-04-15 Rp Scherer Technologies Llc Système d'administration pharmaceutique à deux phases
WO2015001478A1 (fr) * 2013-07-01 2015-01-08 Aventis Pharmaceuticals Inc. Composition pharmaceutique liquide pour une administration orale, comprenant de la fexofénadine
US20150010622A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
CN103610645B (zh) * 2013-11-25 2016-05-11 浙江万晟药业有限公司 一种非索非那定盐酸盐的药物组合物及制备方法
CN106806346B (zh) * 2015-12-01 2020-09-11 国药集团广东环球制药有限公司 一种非索非那定盐酸盐干混悬剂制剂及其制备方法
US11207307B2 (en) * 2016-06-16 2021-12-28 Azurity Pharmaceuticals, Inc. Composition and method for proton pump inhibitor suspension
JP7169671B2 (ja) 2017-06-02 2022-11-11 テイカ製薬株式会社 難水溶性成分可溶化ミセル及びそれを含有する液剤
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
US20230321319A1 (en) * 2020-08-18 2023-10-12 Innate S.R.L. Injectable composition and use of said composition
WO2022175829A1 (fr) 2021-02-17 2022-08-25 Cellix Bio Private Limited Formulations et compositions topiques
MX2024008242A (es) * 2021-12-29 2024-07-19 Opella Healthcare Group Sas Composiciones que contienen fexofenadina.
CN115715759B (zh) * 2022-11-03 2024-01-12 京海盛达(北京)科技有限公司 一种抗组胺混悬剂及其制备方法
CA3260005A1 (fr) * 2023-01-20 2024-07-25 Opella Healthcare Group Sas Formulations de fexofénadine sans parabène

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2189007C (fr) * 1994-05-18 2004-03-02 Daniel R. Henton Methodes pour preparer des formes anhydres et hydratees de derives antihistaminiques de la piperidine; leurs formes polymorphes et pseudomorphes
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
ES2301662T3 (es) 2001-07-31 2008-07-01 Texcontor Etablissement Polimorfo de clorhidrato de fexofenadina.
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
ATE444731T1 (de) * 2003-01-30 2009-10-15 Ethypharm Sa Geschmacksmaskierte beschichtete teilchen, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die beschichteten teilchen
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
EP1827499A4 (fr) * 2004-11-24 2010-03-17 Medpointe Healthcare Inc Compositions comportant de l'azelastine et leurs procedes d'utilisation
AU2006278874A1 (en) 2005-07-27 2007-02-15 Sandoz Ag A process for the preparation of substituted phenyl ether compounds and rosiglitazone
WO2007017905A1 (fr) * 2005-08-05 2007-02-15 Lupin Limited Compositions pharmaceutiques de fexofenadine sous forme de suspension et destinees a une administration par voie orale

Also Published As

Publication number Publication date
RU2008128418A (ru) 2010-01-20
ES2327168T3 (es) 2009-10-26
EG25866A (en) 2012-09-12
US20080299211A1 (en) 2008-12-04
DOP2006000274A (es) 2007-10-15
CN101316580A (zh) 2008-12-03
HK1123197A1 (en) 2009-06-12
US8933097B2 (en) 2015-01-13
AR058323A1 (es) 2008-01-30
DE602006006870D1 (de) 2009-06-25
AU2006326551A1 (en) 2007-06-21
KR101452792B1 (ko) 2014-10-22
NO20082904L (no) 2008-09-10
WO2007070517A2 (fr) 2007-06-21
ATE431137T1 (de) 2009-05-15
IL192067A0 (en) 2009-02-11
CR9993A (es) 2008-09-23
JO2549B1 (en) 2010-09-05
ZA200803985B (en) 2009-03-25
HRP20090411T1 (hr) 2010-01-31
TWI377061B (en) 2012-11-21
CA2633086C (fr) 2011-10-18
DK1965768T3 (da) 2009-09-07
MY146988A (en) 2012-10-15
BRPI0619895B1 (pt) 2022-04-12
PL1965768T3 (pl) 2009-11-30
BRPI0619895A2 (pt) 2011-10-25
HN2008000875A (es) 2012-01-30
EP1965768B1 (fr) 2009-05-13
NZ568943A (en) 2010-04-30
CN101316580B (zh) 2011-11-16
NO339877B1 (no) 2017-02-13
CA2633086A1 (fr) 2007-06-21
AU2006326551B2 (en) 2012-06-07
UY30021A1 (es) 2007-07-31
RS51135B (sr) 2010-10-31
JP5308824B2 (ja) 2013-10-09
RU2405538C2 (ru) 2010-12-10
UA89584C2 (en) 2010-02-10
KR20080074180A (ko) 2008-08-12
SI1965768T1 (sl) 2009-10-31
PE20071003A1 (es) 2007-10-03
CY1109320T1 (el) 2014-07-02
PT1965768E (pt) 2009-08-07
TW200812581A (en) 2008-03-16
TNSN08186A1 (en) 2009-10-30
IL192067A (en) 2010-12-30
ECSP088532A (es) 2008-08-29
WO2007070517A3 (fr) 2007-08-23
JP2009519935A (ja) 2009-05-21
EP1965768A2 (fr) 2008-09-10

Similar Documents

Publication Publication Date Title
MA30152B1 (fr) Suspension de fexofenadine
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
UY28290A1 (es) Compuestos farmacéuticos novedosos
EP1875894A3 (fr) Utilisation d'au moins un dérivé C-glycoside à titre d'agent apaisant
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
EP1905456A4 (fr) Gel dérivé de l'acide hyaluronique photoréticulé contenant un médicament
SG161311A1 (en) Novel use of spiegelmers
EP1712240A4 (fr) Preparation medicamenteuse aqueuse stable contenant un anticorps
DE602004031372D1 (de) Nachweis von staphylococcus
MXPA05012463A (es) Combinaciones farmaceuticas de un inhibidor de bomba protonica y un compuesto que modifica la motilidad gastrointestinal.
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
TWI350757B (en) Aqueous suspensions of ciclesonide for nebulisation
SE9901077D0 (sv) Novel use
MA31430B1 (fr) Formulation a liberation prolongee de nevirapine
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
EA200900261A1 (ru) Применение эсцина
TNSN04138A1 (fr) Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetique
NO20063293L (no) Farmasoytiske forbindelser
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
MA27772A1 (fr) Preparation pharmaceutique orale destinee aux antagonistes de la pompe a protons
SE0102910D0 (sv) New use
DE602006010852D1 (de) Proliferationshemmendes arzneimittel
NO20064783L (no) Opplosningstabeletter med licarbazepin
ITRM20010309A0 (it) Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica.